West Pharmaceutical Services, Inc. (FRA:WPS)

FRA:WPS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	509.7	484.6	853.9	894.3	762.6	615.5
Cash & Short-Term Investments	509.7	484.6	853.9	894.3	762.6	615.5
Cash Growth	14.23%	-43.25%	-4.52%	17.27%	23.90%	40.17%
Receivables	610.3	575.8	533.5	523.7	503.6	385.3
Inventory	421.1	377	434.7	414.8	378.4	321.3
Other Current Assets	139.8	100.7	114.3	86.7	97.4	51.6
Total Current Assets	1,681	1,538	1,936	1,920	1,742	1,374
Property, Plant & Equipment	1,861	1,716	1,513	1,263	1,127	1,012
Long-Term Investments	224.7	202.1	210	204.9	207.7	214.7
Goodwill	110.9	106	108.5	107.3	109.9	111.1
Other Intangible Assets	9.7	10.8	15.1	18.4	23	30.5
Long-Term Accounts Receivable	-	-	-	-	-	10.9
Long-Term Deferred Tax Assets	29.7	26	25.7	65.6	48.5	16
Long-Term Deferred Charges	-	-	-	-	-	0.4
Other Long-Term Assets	35.5	44.6	21.3	38.4	55.9	25
Total Assets	3,953	3,643	3,830	3,617	3,314	2,794
Accounts Payable	239	239.3	242.4	215.4	232.2	213.1
Accrued Expenses	93.4	138	161.3	141.1	186.1	149.1
Current Portion of Long-Term Debt	-	-	134	2.2	44.2	2.3
Current Portion of Leases	22.2	18.8	17.7	16	9.3	10.1
Current Income Taxes Payable	28.5	31.5	16.6	29.5	26.3	26
Current Unearned Revenue	-	49.6	41.7	57.3	48.7	51
Other Current Liabilities	221.5	73.2	58.1	57.5	47.3	51.8
Total Current Liabilities	604.6	550.4	671.8	519	594.1	503.4
Long-Term Debt	202.6	202.6	72.8	206.7	208.8	258.5
Long-Term Leases	83.4	83.9	84.5	93	63	60.4
Long-Term Unearned Revenue	-	3.6	12.2	10.9	-	-
Long-Term Deferred Tax Liabilities	23	20.5	12.7	14.3	4.9	10.4
Other Long-Term Liabilities	79.3	71.9	64.9	59.8	67.1	49.1
Total Liabilities	1,024	961.1	948.5	931.9	978.4	939.3
Common Stock	18.8	18.8	18.8	18.8	18.8	18.8
Additional Paid-In Capital	-	22.1	120.2	232.2	249	267.3
Retained Earnings	4,139	3,957	3,523	2,988	2,457	1,847
Treasury Stock	-1,140	-1,057	-637.6	-370.9	-229.5	-167.7
Comprehensive Income & Other	-88.7	-258.1	-143.8	-183	-159.6	-110.6
Shareholders' Equity	2,929	2,682	2,881	2,685	2,335	1,855
Total Liabilities & Equity	3,953	3,643	3,830	3,617	3,314	2,794
Total Debt	308.2	305.3	309	317.9	325.3	331.3
Net Cash (Debt)	201.5	179.3	544.9	576.4	437.3	284.2
Net Cash Growth	52.42%	-67.09%	-5.46%	31.81%	53.87%	162.18%
Net Cash Per Share	2.76	2.43	7.24	7.60	5.73	3.75
Filing Date Shares Outstanding	71.91	72.3	73.3	74.14	74.28	74.1
Total Common Shares Outstanding	71.9	72.3	73.5	74.1	74.2	74.02
Working Capital	1,076	987.7	1,265	1,401	1,148	870.3
Book Value Per Share	40.74	37.10	39.20	36.23	31.47	25.05
Tangible Book Value	2,809	2,566	2,757	2,559	2,203	1,713
Tangible Book Value Per Share	39.06	35.48	37.52	34.54	29.68	23.14
Land	-	27.9	33.7	29	29.3	24.8
Buildings	-	916.1	771.5	663.6	644.8	618.1
Machinery	-	1,631	1,518	1,388	1,298	1,201
Construction In Progress	-	410.8	415.2	305.9	242.7	192.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.